204 related articles for article (PubMed ID: 1675924)
1. The action of (+/-)-MDMA on medial prefrontal cortical neurons is mediated through the serotonergic system.
Pan HS; Wang RY
Brain Res; 1991 Mar; 543(1):56-60. PubMed ID: 1675924
[TBL] [Abstract][Full Text] [Related]
2. MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system.
Pan HS; Wang RY
Brain Res; 1991 Jan; 539(2):332-6. PubMed ID: 1675911
[TBL] [Abstract][Full Text] [Related]
3. Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity.
Brodkin J; Malyala A; Nash JF
Pharmacol Biochem Behav; 1993 Jul; 45(3):647-53. PubMed ID: 8101380
[TBL] [Abstract][Full Text] [Related]
4. Effects of MDMA ('ecstasy') on firing rates of serotonergic, dopaminergic, and noradrenergic neurons in the rat.
Piercey MF; Lum JT; Palmer JR
Brain Res; 1990 Sep; 526(2):203-6. PubMed ID: 1979517
[TBL] [Abstract][Full Text] [Related]
5. Examination of the action of 3,4-methylenedioxymethamphetamine on rat A10 dopamine neurons.
Gifford AN; Minabe Y; Toor A; Wang RY; Ashby CR
Synapse; 1996 May; 23(1):52-7. PubMed ID: 8723135
[TBL] [Abstract][Full Text] [Related]
6. The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine.
Schmidt CJ; Black CK; Taylor VL; Fadayel GM; Humphreys TM; Nieduzak TR; Sorensen SM
Eur J Pharmacol; 1992 Sep; 220(2-3):151-9. PubMed ID: 1425989
[TBL] [Abstract][Full Text] [Related]
7. The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study.
Minabe Y; Emori K; Ashby CR
Synapse; 1996 Jan; 22(1):46-53. PubMed ID: 8822477
[TBL] [Abstract][Full Text] [Related]
8. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
Stone DM; Johnson M; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1988 Oct; 247(1):79-87. PubMed ID: 2902215
[TBL] [Abstract][Full Text] [Related]
9. (+/-)-3,4-Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons.
Kelland MD; Freeman AS; Chiodo LA
Eur J Pharmacol; 1989 Oct; 169(1):11-21. PubMed ID: 2574685
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the ability of clozapine to facilitate NMDA- and electrically evoked responses in pyramidal cells of the rat medial prefrontal cortex by dopamine: pharmacological evidence.
Ninan I; Wang RY
Eur J Neurosci; 2003 Mar; 17(6):1306-12. PubMed ID: 12670320
[TBL] [Abstract][Full Text] [Related]
11. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
Nash JF; Meltzer HY; Gudelsky GA
J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523
[TBL] [Abstract][Full Text] [Related]
12. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
Callaway CW; Wing LL; Geyer MA
J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
[TBL] [Abstract][Full Text] [Related]
13. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin.
Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK
Eur J Pharmacol; 1989 Aug; 167(3):375-83. PubMed ID: 2572435
[TBL] [Abstract][Full Text] [Related]
14. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
Mokler DJ; Robinson SE; Rosecrans JA
Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440
[TBL] [Abstract][Full Text] [Related]
15. Influence of PCPA and MDMA (ecstasy) on physiology, development and behavior in Drosophila melanogaster.
Dasari S; Viele K; Turner AC; Cooper RL
Eur J Neurosci; 2007 Jul; 26(2):424-38. PubMed ID: 17650115
[TBL] [Abstract][Full Text] [Related]
16. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography.
Battaglia G; Sharkey J; Kuhar MJ; de Souza EB
Synapse; 1991 Aug; 8(4):249-60. PubMed ID: 1681594
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin.
Gazzara RA; Takeda H; Cho AK; Howard SG
Eur J Pharmacol; 1989 Sep; 168(2):209-17. PubMed ID: 2575036
[TBL] [Abstract][Full Text] [Related]
18. Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats.
Matthews RT; Champney TH; Frye GD
Pharmacol Biochem Behav; 1989 Aug; 33(4):741-7. PubMed ID: 2575758
[TBL] [Abstract][Full Text] [Related]
19. Monoaminergic mechanisms of stimulation-produced analgesia.
Akil H; Liebeskind JC
Brain Res; 1975 Aug; 94(2):279-96. PubMed ID: 125141
[TBL] [Abstract][Full Text] [Related]
20. Chloral hydrate anesthesia antagonizes the neurotoxicity of 3,4-methylenedioxymethamphetamine.
Schmidt CJ; Black CK; Abbate GM; Taylor VL
Eur J Pharmacol; 1990 Nov; 191(2):213-6. PubMed ID: 1982264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
